Ltopgraphic   RtopGraphic
Vtgraphic
RMC Logo

New! Visit RMC's Blog

New! Bolt-on CMC

Quality Services

Compliance Services

Process and Product Development

Analytical Development,
QC and Stability

Biosafety Services

Protein and mAb Development

In-House Laboratory Services

Validation and Calibration

Project Management

Facility Service

Strategic Planning

Due Diligence

Useful Resource Links

spacer
  spacer

Tim JoyTim Joy

Beyond serving as President of RMC, Tim assists clients with creating, developing, and/or executing and achieving their own measured solutions to both the individual and interrelated compliance, quality and development responsibilities of product development and commercialization programs. Additionally, with contemporary hands-on experience evaluating and monitoring GxP quality systems in Asia , North America and Europe, Tim possesses a current global perspective of precisely what is taking place to balance and achieve the varied compliance, quality and overall drug development objectives of numerous organizations throughout these key regions.

 

Scott RudgeScott Rudge

Since co-founding RMC Pharmaceutical Solutions in May 2004, Scott has been involved in a wide variety of projects for small and large biotech/pharmaceutical companies. He has overseen and/or performed assay, equipment, sterilization, cleaning and process validation, formulation development, due diligence for a multimillion dollar investment, construction of a new GMP facility for tissue processing, and tech transfer for a major late stage biotechnology product.  In his last position, Scott served as the Vice President of Operations at FeRx Incorporated, overseeing manufacturing, process and product development, analytical development, formulation, facility design, construction and operation, and intellectual property.

 

raymond nimsRaymond Nims

Raymond Nims brings over 35 years of experience in the biomedical sciences. From 2006 to 2009, Ray served in Amgen’s Corporate Quality Control group, providing subject matter expertise in viral and mycoplasma testing of raw materials and products, and serving as business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, Ray directed laboratories at BioReliance performing viral safety, endotoxin, and cell line identity studies for biologics cell line characterization, raw material testing, and product lot release testing. From 1985 to 1994, Ray served as a Chemist at the National Cancer Institutes’ Laboratory of Chemical Carcinogenesis, and from 1974 to 1985 Ray held a variety of technical and supervisory positions at Microbiological Associates, a contract research organization.

Raymond obtained a PhD in Chemistry (Chemical Toxicology) at The American University, Washington, DC, in 1993. He currently serves on the editorial board for the International Journal of Toxicology, and has served on the ad hoc advisory boards for USP chapters 1237 and 1050. He is a generalist in the Biomedical Sciences, with a publication list spanning a wide range of areas in Chemistry, Carcinogenesis, Biochemistry, Pharmacology, Toxicology, and Virology.

 

lori nixonLori Nixon

Dr. Nixon has been with RMC since 2005, and has over 18 years of experience in the bio/pharma industry, with a focus on analytical development and quality control.  She received her PhD in Analytical Chemistry from the University of Colorado at Boulder and subsquently worked in Process Development and Analytical groups at Synergen and Amgen, Inc.  She was formerly head of Analytical Sciences at Amgen Colorado.

Since joining RMC, Lori has worked with a variety of biotech and pharma clients to develop and oversee analytical and bioanalytical programs and activities including method development, transfer and validation; stability; sampling plans; formulation development; product specifications; reference standards and critical reagents development; laboratory audits and more.   She has worked with a variety of therapeutics including recombinant proteins, monoclonal antibodies, oligonucleotides, synthetic peptides and other small molecules and has worked with products both in early (pre-IND) and late (post-commercial) stages.

 

joanne izykJoanne Izyk

Joanne Izyk brings over 15 years of experience to RMC and its clients, predominantly in the pharmaceutical industry – but also supplemented with direct horticultural and science education experience as well. Immediately prior to joining RMC, Joanne was Sr. Manager, QA/QC at FeRx Incorporated where she was responsible for the daily supervision and management of Quality Assurance and Quality Control activities. The operations included internal pharmaceutical manufacturing and testing, pharmaceutical outsourced services and medical device components for combination products.

Joanne’s overall hands-on experience bridges both commercial and development-stage pharmaceutical companies. This experience includes GxP Quality Systems development and management, quality control performance and management (including various chromatographic, wet chemistry & physical testing techniques), analytical research and stability, manufacturing operations oversight and support, technical report writing, regulatory submission review and Laboratory Information Management systems. Joanne also has wide-ranging experience in both North America and Europe auditing and monitoring GMP raw material/excipient suppliers, contract manufacturing and testing operations (API and Drug Product), and labeling/packaging/distribution suppliers.

Joanne earned her B.S. in Secondary Education/Chemistry from the State University of New York at Plattsburgh.

 

Leah Choi

Since joining RMC Pharmaceutical Solutions in November 2006, Leah has been involved in various pharmaceutical and biotechnology projects such as: assisting with the execution of OQ/IQ protocols for a manufacturing clean room; writing standard operating procedures, protocols, and technical transfer documents; assisting in the development and manufacturing process for a pre-clinical drug product; executing QC/QA review of production batch records, raw analytical data, technical reports, stability reports, and regulatory filings; executing some project management tasks; assisting in the design, creation, and implementation of a quality system for a virtual biotech company; executing various document management tasks; and reviewing pipe and instrument drawings, requirement specifications, and functional specifications for a modular CIP system.

Prior to joining RMC, Leah attended the University of Colorado at Boulder, Boulder, Colorado and earned her B.A. in Biochemistry, with a minor in Chemistry. In 2009, Leah also received a Certificate of Good Laboratory Practices/Good Manufacturing Practices form the University of Denver, Denver, Colorado and a Yellow Belt Training Certificate from the Colorado Association for Manufacturing and Technology in Boulder, Colorado.

spacer
TopVgraphic
Lbottomgraphic
Blinegraphic © 2005 - 2008 RMC Pharmaceutical Solutions Incorporated.
RbottomGraphic